Medicine ホーム > High Impact Papers > Medicine > PD-L1 Testing for Lung Cancer in 2019: Perspective From the IASLC Pathology Committee PD-L1 Testing for Lung Cancer in 2019: Perspective From the IASLC Pathology Committee代表者 : 野口 雅之 © University of Tsukuba
